89 related articles for article (PubMed ID: 6171949)
1. Failure of a commercial, intravenously applicable IgG F (ab)2 preparation (Gamma-Venin) to enhance human serum bactericidal activity against Serratia marcescens.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):504-11. PubMed ID: 6171949
[TBL] [Abstract][Full Text] [Related]
2. Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):84-91. PubMed ID: 7032154
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
Traub WH
Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
[TBL] [Abstract][Full Text] [Related]
4. Phagocytosis of Serratia marcescens by leukocytes of fresh defibrinated human blood: failure of "natural" human specific anti-O IgG antibodies to enhance phagocytosis.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):92-103. PubMed ID: 7032156
[TBL] [Abstract][Full Text] [Related]
5. Opsonization requirements of Serratia marcescens.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):204-24. PubMed ID: 6187137
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
Traub WH; Fukushima PI
Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
[TBL] [Abstract][Full Text] [Related]
7. Failure of the commercial human IgG immunoglobulin preparation Polyglobin to enhance combined phagocytic and serum bactericidal activity of normal blood against Serratia marcescens.
Traub WH
Chemotherapy; 1983; 29(1):43-7. PubMed ID: 6339179
[TBL] [Abstract][Full Text] [Related]
8. Towards serodiagnosis of Serratia marcescens infections: examination of sera from noninfected patients and from experimentally infected rabbits for anti-H and anti-O antibodies; S. marcescens O-antigen cross-reactions with those of other enterobacteriaceae.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):490-6. PubMed ID: 7036590
[TBL] [Abstract][Full Text] [Related]
9. Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.
Traub WH; Fukushima PI
Zentralbl Bakteriol Orig A; 1979; 245(3):301-11. PubMed ID: 44784
[TBL] [Abstract][Full Text] [Related]
10. Passive protection of NMRI mice against Serratia marcescens: comparative efficacy of commercial human IgG immunoglobulin preparations and rabbit anti-O, -H, -K, -life cell and -protease immune sera.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):480-8. PubMed ID: 6202079
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of human serum bactericidal activity by specific IgM antibodies of normal and anti-O immune rabbit sera against pseudo-serum-resistant strains of Serratia marcescens.
Traub WH
Zentralbl Bakteriol A; 1980 Feb; 246(1):50-66. PubMed ID: 6999780
[No Abstract] [Full Text] [Related]
12. Serotyping of Serratia marcescens: simplified tube O-agglutination test and comparison with other serological procedures.
Traub WH; Fukushima PI
Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):474-93. PubMed ID: 396741
[TBL] [Abstract][Full Text] [Related]
13. Passive protection of NMRI mice with commercial, intravenously applicable human immunoglobulin IgG preparations against Serratia marcescens.
Traub WH
Chemotherapy; 1986; 32(6):530-6. PubMed ID: 3542407
[TBL] [Abstract][Full Text] [Related]
14. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.
Simberkoff MS; Ricupero I; Rahal JJ
J Lab Clin Med; 1976 Feb; 87(2):206-17. PubMed ID: 1107450
[TBL] [Abstract][Full Text] [Related]
15. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
16. Virulence of nosocomial isolates of Serratia marcescens for NMRI mice: correlation with O-antigens O6 and O14.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):360-9. PubMed ID: 6182709
[TBL] [Abstract][Full Text] [Related]
17. The role of O-antigen in susceptibility of Serratia marcescens to non-immune serum.
Palomar J; Montilla R; Fusté MC; Viñas M
Microbios; 1993; 76(308):189-96. PubMed ID: 8302200
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic activity of selected clinical isolates of Serratia marcescens against human serum proteins.
Doerr M; Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):196-207. PubMed ID: 6181630
[TBL] [Abstract][Full Text] [Related]
19. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. IV. N-formimidoyl thienamycin.
Traub WH
Chemotherapy; 1983; 29(2):121-7. PubMed ID: 6340990
[TBL] [Abstract][Full Text] [Related]
20. Analysis of auto-antigens in the human sperm membrane by a F(ab')2 blocking system.
Hjort T; Poulsen F
J Clin Lab Immunol; 1981 Jul; 6(1):61-7. PubMed ID: 7265177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
